Why Proper CBD Storage Matters More Than Most Consumers Realize

Published June 3, 2026 CBD Products Are Not Immune to Time Many consumers assume that CBD products remain unchanged until their expiration date. While CBD is generally considered a relatively stable cannabinoid, it is still a natural compound that can be affected by its environment. Like other cannabinoids, CBD gradually changes when exposed to oxygen,Continue reading “Why Proper CBD Storage Matters More Than Most Consumers Realize”

More Hemp Products Now Include Minor Cannabinoids Beyond CBD

Published May 22, 2026 CBD Once Dominated the Hemp Industry For years, CBD was almost entirely synonymous with the modern hemp industry. After the 2018 Farm Bill expanded legal hemp production in the United States, CBD rapidly became one of the most recognizable cannabis-derived wellness products in the country. Oils, gummies, tinctures, capsules, beverages, andContinue reading “More Hemp Products Now Include Minor Cannabinoids Beyond CBD”

Many CBD Brands Are Quietly Moving Away From Aggressive Wellness Claims

Published May 16. 2026 CBD Marketing Looks Different Than It Did a Few Years Ago The CBD industry entered the mainstream promising calm, balance, recovery, focus, sleep support, and countless other wellness-oriented benefits. During the first major hemp boom, many companies marketed CBD products using language that often blurred the line between general wellness positioningContinue reading “Many CBD Brands Are Quietly Moving Away From Aggressive Wellness Claims”

FDA Continues Crackdown on CBD Companies Making Unproven Health Claims

Published March 20, 2026 Federal regulators warn businesses against marketing CBD products with medical benefits The U.S. Food and Drug Administration (FDA) is continuing its enforcement efforts against CBD companies that market products with unproven health claims. Regulators say many businesses are still promoting cannabidiol as a treatment for serious medical conditions without sufficient evidence.Continue reading “FDA Continues Crackdown on CBD Companies Making Unproven Health Claims”

FDA Signals New Direction for CBD Regulation in 2026 as Industry Awaits Clear Rules

Published March 17, 2026 Federal regulators are under growing pressure to establish a national framework for CBD products as the hemp market continues to expand The U.S. Food and Drug Administration is signaling renewed movement on CBD regulation in 2026, as lawmakers and industry stakeholders push for clearer federal rules. Since the passage of theContinue reading “FDA Signals New Direction for CBD Regulation in 2026 as Industry Awaits Clear Rules”